ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Stephanie Pappas

Stephanie Pappas

Stephanie Pappas is a freelance science writer and a contributing writer for Rheumatology Network. She has worked as a science writer for Live Science covering psychology and neuroscience. She’s also written for the Stanford University School of Medicine Office of Communication & Public Affairs. She is a graduate of the University of California, Santa Cruz, science writing program.

Posts by Author

©bleakstar/Shuttersstock.com

The 2015 recommendations for PsA treatment highlight the importance of managing comorbidities and a patient-centered treatment approach.

Tick (©Smileus/Shutterstock.com)

Identifying the difference between Lyme arthritis or another inflammatory arthritis can be tricky. Here are key signs that your patient may have a systemic inflammatory arthritis rather than Lyme arthritis.

Lyme disease rash (©AnastasiaKopaShutterstock.com)

When a patient presents with a history of Lyme disease and joint pain, refractory Lyme arthritis seems reasonable, but then, this study warns of systemic arthritis after a Lyme disease infection.

(©KPG_Payless/Shutterstock.com)

When methotrexate fails in rheumatoid arthritis, the next-line treatment is usually a TNF-α inhibitor. But if this treatment fails as well, what's next?

Bone with osteoperosis (©Lightspring/Shutterstock.com)

Low bone mineral density and osteoporosis are well-known comorbidities with systemic lupus erythematosus. In this slideshow, we highlight six of the most common risk factors for low bone mineral density in SLE.

©Lightspring/Shutterstock.com

Age and cumulative glucocorticoid exposure are key risk factors for low bone mineral density in systemic lupus erythematosus.

(©Wallybird/Shutterstock.com)

For high risk patients with systemic lupus erythematosus, teriparatide and denosumab may be an option for patients who have failed bisphosphonates. Here are some key points you need to know.

©donskarpo/Shutterstock.com

Bone loss could affect as many as 31 percent of SLE patients. This article sums up the treatment options from first-line bisphosphonate recommendations to emerging treatments like abaloparatide.

Elderly falls (©Toa55/Shutterstock.com)

All patients about to undergo surgery should be preoperatively evaluated for fall history, a study shows.

(©ksenvitaln/Shutterstock.com)

Q&A: Two experts discuss proposals for formal CVD risk calculators in RA and the need for long-term research to validate them.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.